Delivery Order SPE2DB20D2104-SPE2DB24FS11U
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,360.80 delivery order is for the medical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" and has a period of performance through February 27, 2024. The contract is a firm fixed price delivery order, indicating the government procured a specific quantity of the product at a pre-determined price. This award is not associated with a set-aside...
- This federal contract award is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $1,353.80, is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,504.80, is for the delivery of pharmaceutical products, including the drug ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $17,699.61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for a delivery order of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of March 7, 2024. The contract type is Firm Fixed Price. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products and medical supplies. The contract, valued at $8,713.38, is a Firm Fixed Price Delivery Order with a completion date of February 8, 2024. The award is for the supply of a specific drug, "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML," and does not have a set-aside designation, indicating open competition....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,475.14 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of pharmaceutical products, including the drug ZEPBOUND, to support military healthcare programs. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp has established itself as...
- This federal contract award, valued at $32,564.79, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $50,724.28, is a delivery order for the medical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML." The contract has a completion date of February 13, 2024 and is a firm fixed-price type. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,707.60 firm fixed-price delivery order is for the medical product "ZEPBOUND 15 MG/0.5 ML PEN 0.5ML" and has a completion date of February 9, 2024. The contract has no set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,658.32 firm fixed-price delivery order is for the pharmaceutical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML." This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS11UDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products and medical supplies. The award, valued at $15,164.66, is a Firm Fixed Price delivery order contract with a completion date of January 19, 2024. The contract covers the procurement of a specific medical product, "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML," with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.2k | 1/18/24 |